Development of inhalable atra-loaded plga nanoparticles as host-directed immunotherapy against tuberculosis

HIGHLIGHTS

• who: ATRA and collaborators from the School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in (RCSI), College, The University of, WRT have published the research: Development of Inhalable ATRA-Loaded PLGA NanopArticles as Host-Directed Immunotherapy against Tuberculosis, in the Journal: Pharmaceutics 2022, 14, 1745. of /2022/
• what: The authors aim to develop inhalable ATRAloaded polymeric NPs to deliver ATRA to the lungs and to maximize intracellular uptake of the nanoparticles by macrophages.
• how: The authors used acetone as an organic solvent due to its low toxic potential to human health . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.